Carnegie Investment Counsel’s iShares iBonds Dec 2022 Term Corporate ETF IBDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-12,408
Closed -$300K 426
2018
Q4
$300K Buy
+12,408
New +$300K 0.03% 314

Other funds holding IBDN

Carnegie Investment Counsel's IBDN Position: Q1 2019 in Review

Carnegie Investment Counsel sold out of iShares iBonds Dec 2022 Term Corporate ETF (IBDN) in Q1 2019, closing a stake of 12,408 shares — an estimated $300K sold.

Carnegie Investment Counsel first reported a position in IBDN in Q4 2018 and held it in 1 quarter. The position peaked at $300K in Q4 2018. 124 funds tracked by Wall St. Rank hold IBDN as of Q1 2019.

  • Carnegie Investment Counsel reported no remaining iShares iBonds Dec 2022 Term Corporate ETF position as of Q1 2019 after selling out during the quarter.
  • Carnegie Investment Counsel sold 12,408 iShares iBonds Dec 2022 Term Corporate ETF shares in Q1 2019, an estimated $300K.
  • Carnegie Investment Counsel first reported a position in iShares iBonds Dec 2022 Term Corporate ETF in Q4 2018 and held it in 1 quarter.
  • Carnegie Investment Counsel's iShares iBonds Dec 2022 Term Corporate ETF position peaked at $300K in Q4 2018.
  • 124 funds tracked by Wall St. Rank held iShares iBonds Dec 2022 Term Corporate ETF as of Q1 2019.

Based on Carnegie Investment Counsel's 13F filing for Q1 2019, filed 14 May 2019.